高级检索
当前位置: 首页 > 详情页

Acupuncture therapy protects PCOS patients with diabetes by regulating miR-32-3p/PLA2G4A pathway.

| 认领 | 导出 |

文献详情

资源类型:
Pubmed体系:

收录情况: ◇ 预警期刊

机构: [1]The First Clinical Medical College of Guangzhou University of Chinese Medicine Guangzhou, Guangdong Province, China. [2]Department of TCM Gynecology, Shunde Women and Children's Hospital of Guangdong Medical University Foshan, Guangdong Province, China. [3]Rehabilitation Care Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou, Guangdong Province, China.
出处:
ISSN:

摘要:
To investigate the potential miRNA-mRNA network co-expressed in polycystic ovary syndrome (PCOS) and diabetes, and explore the molecular mechanism of traditional acupuncture treatment of PCOS.Patients with PCOS and diabetes who had undergone acupuncture treatment from January 2019 to June 2020 were recruited in this study. The potential miRNA-mRNA network co-expressed in PCOS and diabetes was obtained through bioinformatics analysis. The expression levels of candidate gen es were determined using quantitative qRT-PCR to study the effectiveness of acupuncture approach. Further, the mechanism of action of acupuncture method was determined using luciferase assay.A total of 44 patients were included in this study. The miRNA-mRNA network for PCOS was then constructed based on the results of the bioinformatics analysis. Acupuncture treatment could significantly down-regulate miR-32-3p levels and up-regulate expression of PLA2G4A. Luciferase experiments showed that miR-32-3p could affect glucose metabolism in PCOS patients through down-regulating PLA2G4A expression. Functional and pathway enrichment analysis further suported this finding.MiR-32-3p regulates PLA2G4A protein expression, which is vital in the pathogenesis of PCOS and diabetes. Further, this research proved that the potential mechanism of traditional acupuncture treatment may be the downregulation of miR-32-3p, thus inhibiting PCOS and diabetes progression.AJTR Copyright © 2021.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 3 区 医学:研究与实验 3 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
第一作者:
第一作者机构: [1]The First Clinical Medical College of Guangzhou University of Chinese Medicine Guangzhou, Guangdong Province, China. [2]Department of TCM Gynecology, Shunde Women and Children's Hospital of Guangdong Medical University Foshan, Guangdong Province, China.
通讯作者:
通讯机构: [3]Rehabilitation Care Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou, Guangdong Province, China. [*1]Rehabilitation Care Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, No. 16 Airport Road, Baiyun District, Guangzhou 510405, Guangdong Province, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号